Patents by Inventor Pamela Wang Anderson

Pamela Wang Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for inhibiting cataracts
    Publication number: 20040087572
    Abstract: This invention relates to a method for inhibiting cataracts comprising administering to a patient in need thereof an effective amount of a compound of the formula (I); or a pharmaceutical salt or solvate thereof wherein: R1 and R3 are independently hydrogen, methyl, benzoyl, substituted benzoyl, or C(O)—(C1-C6 alkyl); R2 is selected from the group pyrolidin-1-yl, piperidin-1-yl, and hexamethyleneimin-1-yl; where the R2 group is optionally the N-oxide.
    Type: Application
    Filed: March 7, 2003
    Publication date: May 6, 2004
    Inventors: Pamela Wang Anderson, Andreas Sashegyi
  • Method for reducing levels of homocysteine and C-reactive protein
    Patent number: 6353003
    Abstract: The current invention relates to a method for decreasing levels of homocysteine and/or C-reactive protein in humans comprising administering to a mammal in need thereof an effective amount of a compound of formula I: or a pharmaceutical salt or solvate thereof.
    Type: Grant
    Filed: May 3, 1999
    Date of Patent: March 5, 2002
    Assignee: Eli Lilly and Company
    Inventor: Pamela Wang Anderson
  • Methods for reducing fibrinogen
    Patent number: 6025373
    Abstract: The invention is related to reducing fibrinogen in a human by administering a 2-aroyl-3-arylbenzo[b]thiophene compound.
    Type: Grant
    Filed: April 8, 1998
    Date of Patent: February 15, 2000
    Assignee: Eli Lilly and Company
    Inventor: Pamela Wang Anderson